Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Mankind Pharma Ltd.
NSE: MANKIND
|
BSE: 543904
|
ISIN: INE634S01028
|
Industry: Pharmaceuticals
Merger Approval
High Gain High Volume
|
Mid-range Performer
2502.5000
190.50
(
8.24
%)
NSE
Oct 27, 2026
15:31 PM
31.04% Gain from 52W Low
Volume:
3.0M
High volume+gain today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Mankind Pharma Ltd.
16 Dec 2025
Merger Approval
High Gain High Volume
2502.50
8.24%
BP Equities Mankind Pharma Initiating Coverage BUY Target 2,652
Buy:
Mankind Pharma Ltd.
by
BP Wealth
Target: 2652 | Upside : 6.0%
BP Wealth
Mankind Pharma has gained
11.06%
in the last 1 Week
More from Mankind Pharma Ltd.
All Rapid Results
Recommended
Market closes flat, weighed down by losses in IT stocks
Trendlyne Marketwatch |
27 Oct 2026, 04:04PM
Primary market awaits Jio Platforms' listing as nine new issues enter the pipeline
|
26 Oct 2026, 05:33PM
Pre Monday: An optimist surveys the market during earnings season
The Baseline |
24 Oct 2026